16.03.2015
Alphaform AG DE0005487953
DGAP-Adhoc: Alphaform AG: resolves on capital increase from authorised capital with pre-emption rights disapplied
Alphaform AG / Key word(s): Capital Increase
16.03.2015 08:19
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Ad-hoc release
Alphaform AG/Capital Increase
Alphaform AG resolves on capital increase from authorised capital with
pre-emption rights disapplied
Placement price of EUR 2,60
Feldkirchen, 16 March 2015 - The Management Board of Europe's leading
industrial 3D printing service provider Alphaform AG, with the approval of
the Supervisory Board and based on authorised capital under the Articles of
Association, today resolved to increase the share capital in exchange for
cash contributions. The increase is of EUR 417,441.00 from EUR 7,485,387.00
to EUR 7,902,828.00 and is to be implemented by issuing up to 417,441
no-par value bearer shares at a notional value of EUR 1.00 per share with a
profit-sharing entitlement from 1 January 2014. Shareholders' pre-emptive
subscription rights will be disapplied.
The new shares will be subscribed for by Oddo Seydler Bank AG, Frankfurt,
at an issue price of EUR 1.00 and with an obligation to offer the shares to
institutional investors in a private placement at a placement price of EUR
2,60. Assuming full placement, the company will receive a total of
approximately EUR 1,1 million less commission and costs.
The new shares are to be admitted to trading on the stock exchange without
a listing prospectus and included in the existing listing in the Prime
Standard segment of the regulated market on the Frankfurt stock exchange.
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
About Alphaform
Founded in 1996 and headquartered in Feldkirchen near Munich, Alphaform AG
is a leading European handler for the renovation of industrial development
and production with innovative 3D printing and rapid technologies. As a
service provider, Alphaform guides its clients from product development
through to product manufacture; it assists them in introducing and
utilising innovations and delivers expertise, engineering knowledge,
prototypes, individual parts, small-scale series, series and project
management.
Among others, Alphaform today serves the premium manufacturers of the
automotive industry, mechanical, plant and automotive engineering, the
aerospace industry, tool making and medical technology. Its particular
areas of expertise include complex assembly, lightweight construction and
orthopaedic implants and instruments. It has subsidiaries in Germany,
Finland, Sweden and the UK. Alphaform's shares are listed in the Prime
Standard segment of the Frankfurt stock exchange (code: ATF; securities
code number (WKN): 548 795).
Contact:
Dr. Hanns-Dieter Aberle, CEO Thomas Kresser, CFO
ALPHAFORM AG ALPHAFORM AG
Kapellenstraße 10 Kapellenstraße 10
85622 Feldkirchen 85622 Feldkirchen
Tel.: +49 89 905002 35 Tel.: +49 89 905002 35
Fax: +49 89 905002 1035 Fax: +49 89 905002 1035
e-mail: [email protected] e-mail: [email protected]
Internet: www.alphaform.de Internet: www.alphaform.de
Disclaimer
This press release/ad-hoc disclosure is not an offer document and does not
constitute an offer of shares of Alphaform AG ('Company') nor an invitation
to an offer to buy or subscribe for shares or securities of the Company but
is provided for information only. This press release/ad-hoc disclosure may
contain forward-looking statements that are subject to risks and
uncertainties, including those pertaining to the anticipated benefits to be
realized from the proposals described herein. Forward-looking statements
may include, in particular, statements about future events, future
financial performance, plans, strategies, expectations, prospects,
competitive environment, regulation and supply and demand. The Company has
based these forward-looking statements on its views and assumptions with
respect to future events and financial performance. Actual financial
performance could differ materially from that projected in the
forward-looking statements due to the inherent uncertainty of estimates,
forecasts and projections, and financial performance may be better or worse
than anticipated. Given these uncertainties, persons should not put undue
reliance on any forward-looking statements. The information contained in
this presentation is subject to change without notice and the Company does
not undertake any duty to update the forward-looking statements, and the
estimates and assumptions associated with them, except to the extent
required by applicable laws and regulations.
Important notice to persons in the United States of America
All information in this press release/ad-hoc disclosure is being made
available in the United States of America only to persons believed by the
Company to be capable of understanding and evaluating the risks of a
transaction. No shares or other securities of the Company have been
registered or otherwise qualify for a public sale or resale under federal
or state laws in the United States of America. Each recipient of
information doing business in or organized under any federal or state laws
in the United States of America or in areas subject to its jurisdiction
represents that it is an 'accredited investor' as defined by Rule 501 or
Regulation D under the Securities Act of 1993 ('the Act') and acknowledges
that none of the shares in the Company will be registered under the Act and
cannot be resold in the absence of such registration or the availability of
an exemption there from. The shares in the Company have not been approved
or disapproved by the United States Securities and Exchange Commission, any
state securities commission or other regulatory authority, nor have any of
these authorities passed judgment upon or endorsed the merits of an
investment in the shares of the Company or the accuracy or adequacy of this
presentation. Any representation to the contrary is a criminal offence.
Important notice to persons in the United Kingdom
All information in this press release/ad-hoc disclosure is being made
available to the recipients on the basis that they are persons covered by
Article 11(3) of the Financial Services Act 1986 (Investment
Advertisements) (Exemptions) Order 1996. By accepting this document the
recipient warrants and represents that he or it is such a person.
16.03.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Alphaform AG
Kapellenstraße 10
85622 Feldkirchen
Germany
Phone: +49 (0)89 905002 - 0
Fax: +49 (0)89 905002 - 90
E-mail: [email protected]
Internet: www.alphaform.de
ISIN: DE0005487953
WKN: 548795
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
Alphaform AG ISIN: DE0005487953 können Sie bei EQS abrufen
Kunststoffe , 548795